搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
8 小时
Starboard Takes Stake in Consumer Products Maker Kenvue, Sources Say
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
2 天
on MSN
Kenvue Stock Jumps After Report It’s in Activist Starboard’s Sights
Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health related sector to attract an activist investor. And ...
23 小时
on MSN
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
1 天
Starboard says Kenvue's skin health segment weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
1 天
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
1 天
Kenvue被激进投资者盯上,另一个拆分要来了?
基金投资者Starboard Value在有报道称该投资者已积累大量股份后,可能会推动 $Kenvue Inc (KVUE)$ 剥离其部分或全部“陷入困境的”皮肤、医疗保健和美容(SHB)部门。 鉴于在过去一年半的时间里,SHB部门一直是该股争论的关键领域,预计Starboard将详细说明它希望管理层对该部门做出的改变——我们怀疑这可能涉及剥离该部门的部分或部。
阿思達克財經網
2 天
美股异动|Kenvue盘前涨约3.6% 消息称对冲基金Starboard Value已入股
10月21日|消费者健康产品公司Kenvue (KVUE.US) 美股盘前涨约3.6%,报22.5美元。消息面上,据路透援引两位知情人士称, 对冲 基金Starboard ...
2 天
Kenvue Stock Rallies After Activist Investor Takes Stake
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...
1 天
10 Analysts Have This To Say About Kenvue
In the assessment of 12-month price targets, analysts unveil insights for Kenvue, presenting an average target of $24.1, a ...
17 小时
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
1 天
Kenvue, Inc.: Strong Brand Portfolio and Strategic Initiatives Drive Buy Rating with $27 ...
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
2 天
Kenvue, Inc. Positioned for Growth Amid Strategic Developments and Activist Influence
J.P. Morgan analyst Andrea Faria Teixeira has maintained their bullish stance on KVUE stock, giving a Buy rating on October 15. Andrea Faria ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈